The U.S. Food and Drug Administration will remove the "black box" warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms -- a major turnaround that's likely to ...
By Mariam Sunny Jan 13 (Reuters) - The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ...
Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...
The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the ...
Conagra Brands added a “GLP-1 Friendly” label to 26 of its Healthy Choice frozen meals in early 2025. The Smoothie King chain ...
Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug ...
The Food and Drug Administration on Tuesday told Eli Lilly and Novo Nordisk to remove warnings about the risk of suicidal ...
University of Connecticut provides funding as a member of The Conversation US. A “black box” warning on a health product sounds pretty scary – maybe even more so when it’s suddenly being taken off the ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results